We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Impact of late administration of corticosteroids in COVID-19 ARDS.
- Authors
Mongardon, Nicolas; Piagnerelli, Michael; Grimaldi, David; Perrot, Bastien; Lascarrou, Jean-Baptiste; Aissaoui, Nadia; Blonz, Gauthier; Carbutti, Giuseppe; Courcelle, Romain; Gaudry, Stéphane; D'hondt, Alain; Higny, Julien; Horlait, Geoffrey; Hraiech, Sami; Lefebvre, Laurent; Lejeune, Francois; Ly, André; Pletschette, Zoe; Sauneuf, Bertrand; Serck, Nicolas
- Abstract
We, therefore, aimed to evaluate the impact of late CTC for COVID-19 ARDS patients versus the absence of CTC administration. We studied patients who did not receive (no CTC group) or received CTC later than 13 days after symptoms onset (75% percentile of patients included in the RECOVERY trial [[1]]) (CTC group). To conclude, while early administration of low-dose CTC should be encouraged in severe COVID-19 pneumonia, late high-dose CTC appear to be non-beneficial in late non-resolving ARDS.
- Subjects
COVID-19; CORTICOSTEROIDS; ADULT respiratory distress syndrome
- Publication
Intensive Care Medicine, 2021, Vol 47, Issue 1, p110
- ISSN
0342-4642
- Publication type
Letter
- DOI
10.1007/s00134-020-06311-z